反応式
[CH:1]1[CH:2]=[CH:3][C:4]([Cl:21])=[C:5]([C:7]2[C:14]3[CH:15]=[C:16]([Cl:19])[CH:17]=[CH:18][C:13]=3[NH:12][C:10](=[O:11])[CH:9]([OH:20])[N:8]=2)[CH:6]=1.C(O)C.C(OCC)(=O)C>C1CCCCC1>[CH:1]1[CH:2]=[CH:3][C:4]([Cl:21])=[C:5]([C:7]2[C:14]3[CH:15]=[C:16]([Cl:19])[CH:17]=[CH:18][C:13]=3[NH:12][C:10](=[O:11])[CH:9]([OH:20])[N:8]=2)[CH:6]=1参加物
4
反応条件
- 温度
- 60 °C
実験手順
Lorazepam ethanol solvate (100 g) was suspended in a 1:1 mixture of ethyl acetate and cyclohexane (800 ml). The suspension was heated to 60° C. for 1 hour with rapid stirring and then cooled to 15° C. The cooled suspension was filtered to recover the lorazepam crystals and the crystals were then washed with ethyl acetate (20 ml). The crystals were dried at 50° C. under 65 mm Hg vacuum for two hours to give crystalline lorazepam (85 g, 90%).
後処理
- temperaturecooled to 15° C
- filtrationThe cooled suspension was filtered
- customto recover the lorazepam crystals
- washthe crystals were then washed with ethyl acetate (20 ml)
- customThe crystals were dried at 50° C. under 65 mm Hg vacuum for two hours
出典と根拠
- ORDレコード
- ord-e77446ecc1754bb68f2c2868bde4cd7e
- 出典データセット
- uspto-grants-2002_02
- 特許番号
- US06350870B2
関連ノート
読み込み中…